GLAXOSMITHKLINE PLC-SPON ADR

GSK stock holders 13F

4 superinvestors reported owning GSK (ADR) according to the gurus' 2020 Q1 reports.

Top 4 gurus who own (GSK) GLAXOSMITHKLINE PLC-SPON ADR

The 4 super investors (holders) owning GSK (by the percentage (%) of portfolio) are Thomas Graham, Alan, Irving Kahns - Kahn Brothers Group (10.70%), Jim Cullen - Cullen Value Fund (2.90%), V. D. Dodge, E. M. Cox - Dodge & Cox Stock Fund (2.08%) and B. Tweedy, Ch. Browne - Tweedy, Browne Co All Funds (US) (0.29%) as of their 2020 Q1 reports.

To check the latest activities of the top GSK shareholders between value investors, please click on the "Activity" tab.

To see the historical data of GSK's holders please click on the "2020 Q1" dropdown menu and select the date.

# of holders: 4
Period: 2020 Q1
Type: ADR
B. Tweedy, Ch. Browne
0.29%
131,705
$47.36
$6,238,000
-3.73% (-5,102)
-0.01%
Jim Cullen
2.90%
13,580
$47.36
$643,182
Thomas Graham, Alan, Irving Kahns
10.70%
1,234,894
$47.36
$58,487,686
-2.77% (-35,208)
-0.31%
V. D. Dodge, E. M. Cox
2.08%
11,305,899
$47.36
$535,475,669
-9.45% (-1,179,801)
-0.22%
Current price: $33.96 28.30% AVG reported hold price*: $47.36

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.